VIEWPOINTS ATS 2024: Maria Belvisi, Sarah Doffman, and Janet Franklin from AstraZeneca & Amgen in a Stimulating Conversation with PharmaShotsBySaurabh ChaubeyOctober 7, 20240Comments
News Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology ByDipanshu DixitOctober 3, 20240Comments
VIEWPOINTS AstraZeneca at ATS’24: Robert Fogel & Dave Singh in a Stimulating Conversation with PharmaShotsBySaurabh ChaubeySeptember 30, 20240Comments
EXCLUSIVE Advancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShotsBySaurabh ChaubeySeptember 30, 20240Comments
News Fresenius Kabi and Formycon Report the US FDA’s Approval of Otulfi (Biosimilar, Stelara) ByDipanshu DixitSeptember 30, 20240Comments
News Formycon and Fresenius Kabi Reports the EC’s Approval of Otulfi (Biosimilar, Stelara) for Serious Inflammatory Diseases ByDipanshu DixitSeptember 27, 20240Comments
News Formycon and Fresenius Kabi Reports the EC’s Approval of Otulfi (Biosimilar, Stelara) for Serious Inflammatory Diseases ByDipanshu DixitSeptember 27, 20240Comments
